The University of California, San Diego is a public land-grant research university in San Diego, California.

During the past decade, University California, San Diego (CRS 4601) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University California, San Diego (CRS 4601)" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University California, San Diego (CRS 4601)" are "COVID-19" (1 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "University California, San Diego (CRS 4601)" in a lesser frequency.

Most popular intervention types in "University California, San Diego (CRS 4601)" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cohort 1" (1 trials) and "Remdesivir" (1 trials). Other intervention names were less common.

The vast majority of trials in "University California, San Diego (CRS 4601)" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University California, San Diego (CRS 4601)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University California, San Diego (CRS 4601), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University California, San Diego (CRS 4601), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".